Usana Health Sciences Inc (USNA)
24.01 x 1 29.29 x 1
Pre-market by (Cboe BZX)
27.18 +0.08 (+0.30%) 04/25/25 [NYSE]
24.01 x 1 29.29 x 1
Pre-market 27.18 unch (unch) 19:00 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | USNA | ORGO | TBPH | ||
| Company | Usana Health Sciences Inc | Organogenesis Holdings Inc | Theravance Bio Ord | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 27.00 | 4.48 | 9.50 | ||
| High | 27.20 | 4.56 | 9.75 | ||
| Low | 26.46 | 4.20 | 9.41 | ||
| Last | 27.18 | 4.56 | 9.75 | ||
| Change | +0.08 | +0.03 | +0.21 | ||
| % Change | +0.30% | +0.66% | +2.20% | ||
| Volume | 295,800 | 886,000 | 215,100 | ||
| 20-Day Average Volume | 217,730 | 1,549,175 | 235,780 | ||
| Previous Close | 27.10 | 4.53 | 9.54 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 25.36 | 4.21 | 8.86 | ||
| 20-Day Raw Stochastic | 77.71% | 89.66% | 100.00% | ||
| 20-Day Relative Strength | 50.27% | 53.31% | 61.43% | ||
| Weighted Alpha | -41.14 | +5.79 | +9.03 | ||
| Today's Opinion | 88% Sell | 72% Buy | 40% Buy | ||
| Previous Opinion | 88% Sell | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.49% since 04/17/25 | +8.06% since 04/17/25 | +13.11% since 04/17/25 | ||
| Low | 23.10 on 04/21/25 | 4.14 on 04/21/25 | 8.52 on 04/21/25 | ||
| High | 28.35 on 04/23/25 | 4.68 on 04/23/25 | 9.75 on 04/25/25 | ||
| 1-Month | |||||
| %Chg | +3.50% since 03/25/25 | -12.64% since 03/25/25 | +4.73% since 03/25/25 | ||
| Low | 23.10 on 04/21/25 | 3.52 on 04/07/25 | 7.90 on 04/07/25 | ||
| High | 28.35 on 04/23/25 | 5.29 on 03/26/25 | 9.75 on 04/25/25 | ||
| 3-Month | |||||
| %Chg | -20.85% since 01/24/25 | +28.09% since 01/24/25 | -6.88% since 01/24/25 | ||
| Low | 23.10 on 04/21/25 | 3.07 on 02/27/25 | 7.90 on 04/07/25 | ||
| High | 36.33 on 02/26/25 | 6.71 on 03/03/25 | 10.46 on 01/27/25 | ||
| 6-Month | |||||
| %Chg | -26.16% since 10/25/24 | +62.86% since 10/25/24 | +14.04% since 10/25/24 | ||
| Low | 23.10 on 04/21/25 | 2.75 on 11/04/24 | 7.90 on 04/07/25 | ||
| High | 41.83 on 11/11/24 | 6.71 on 03/03/25 | 10.90 on 01/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 480,553 | 490,824 | 422,008 | ||
| Shares Outstanding, K | 18,860 | 126,828 | 50,001 | ||
| Annual Sales | 854,500,000 | 482,040,000 | 64,380,000 | ||
| Annual Net Income | 42,030,000 | 860,000 | -56,420,000 | ||
| Last Quarter Sales | 213,610,000 | 126,660,000 | 18,750,000 | ||
| Last Quarter Net Income | 4,450,000 | 7,670,000 | -15,530,000 | ||
| 60-Month Beta | 1.00 | 1.79 | 0.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.73 on 04/22/25 | 0.04 on 02/27/25 | -0.05 on 02/26/25 | ||
| Latest Earnings Date | 04/22/25 | 05/08/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.00 | 0.00 | 0.00 | ||